Annual Drug Patent Expirations for ZEJULA
Zejula is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are six patents protecting this drug.
Drug patent litigation for ZEJULA.
This drug has two hundred and thirty-one patent family members in fifty-three countries.
The generic ingredient in ZEJULA is niraparib tosylate. One supplier is listed for this compound. Additional details are available on the niraparib tosylate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
